You are here

CymaBay

CymaBay Therapeutics Stumbles in NASH Race, Shares Fall

Xconomy

Tue, 06/11/19 - 10:11 am

clinical trials

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Yahoo/Benzinga

Sun, 05/19/19 - 03:59 pm

Bellerophon Therapeutics

Bicycle Therapeutics

Peloton Therapeutics

Upcoming events – a legal verdict for Enbrel and a clinical one for Cymabay

EP Vantage

Sat, 04/13/19 - 12:23 pm

CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis

CP Wire

Tue, 11/13/18 - 10:26 am

primary biliary cholangitis

CymaBay Therapeutics Reports Positive Results from Ph II Study of Seladelpar in Patients with Primary Biliary Cholangitis

Tue, 11/13/18 - 10:02 am

primary biliary cholangitis

CymaBay Initiates Ph III Study of Primary Biliary Cholangitis Drug

CP Wire

Tue, 10/30/18 - 11:22 am

primary biliary cholangitis

clinical trials

CymaBay Announces Positive Efficacy and Safety Results from its Ongoing Phase 2 Study of Seladelpar in Patients with Primary Biliary Cholangitis

CP Wire

Wed, 04/11/18 - 11:57 pm

clinical trials